About Dr. Reddy's Laboratories Limited (DRREDDY)
Dr. Reddy's Laboratories Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Hyderabad, India. DRREDDY has been publicly traded since 1996, giving it 30+ years of trading history.
Dr. Reddy's Laboratories Limited (DRREDDY) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Hyderabad, India and employs approximately 27,811 people. With a market capitalization of $1.1 trillion, DRREDDY is one of the largest publicly traded companies.
DRREDDY trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $1.1 trillion. The company employs approximately 27,811 people worldwide.
Key Statistics
- Current Price
- ₹1,292.30
- Market Cap
- ₹1.08T
- 52-Week High
- ₹1,379.70
- 52-Week Low
- ₹1,020.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
DRREDDY Investment Performance
DRREDDY has gained 1.6% year-to-date in 2026. Over the past 5 years, a $1,000 investment in DRREDDY would have grown to $1,376, representing a 37.6% total return. Since its IPO in 1996, a $1,000 investment would now be worth $134,716.
₹1,000 Invested in Dr. Reddy's Laboratories Limited (DRREDDY)
How much would ₹1,000 invested in DRREDDY be worth today?
What would ₹1,000 invested in DRREDDY 1 year ago be worth today?
A ₹1,000 investment in Dr. Reddy's Laboratories Limited (DRREDDY) in 2025 would be worth ₹1,148 as of May 2026, representing a +14.8% total return.
What would ₹1,000 invested in DRREDDY 3 years ago be worth today?
A ₹1,000 investment in Dr. Reddy's Laboratories Limited (DRREDDY) in 2023 would be worth ₹1,473 as of May 2026, representing a +47.3% total return.
What would ₹1,000 invested in DRREDDY 5 years ago be worth today?
A ₹1,000 investment in Dr. Reddy's Laboratories Limited (DRREDDY) in 2021 would be worth ₹1,376 as of May 2026, representing a +37.6% total return.
What would ₹1,000 invested in DRREDDY 10 years ago be worth today?
A ₹1,000 investment in Dr. Reddy's Laboratories Limited (DRREDDY) in 2016 would be worth ₹2,223 as of May 2026, representing a +122.3% total return.
What would ₹1,000 invested in DRREDDY at IPO be worth today?
A ₹1,000 investment in Dr. Reddy's Laboratories Limited (DRREDDY) at IPO would be worth ₹134,716 as of May 2026, representing a +13371.6% total return.
Monthly Returns Heatmap
Over the past 30+ years (362 months), Dr. Reddy's Laboratories Limited (DRREDDY) has averaged a monthly return of +1.83% with a median return of +1.56%. The stock had 214 positive months (59%) and 148 negative months (41%). The best month in DRREDDY's history was March 1999 with a +49.5% return, while the worst was October 1999 at -28.0%. Historically, March tends to be the strongest month (averaging +4.0%), and January the weakest (-1.2%).
DRREDDY's longest winning streak was 12 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 1999 with a cumulative return of +130.5%, and the worst was 2004 at -43.8%.
Annual Returns
Over 30 years of trading history, Dr. Reddy's Laboratories Limited (DRREDDY) has delivered an average annual return of +27.23% with a median return of +12.23%. The compound annual growth rate (CAGR) is +19.13%. The stock posted gains in 18 years (60%) and losses in 12 years (40%).
DRREDDY's best year was 1999 with a +186.31% gain, while the worst was 2004 at -39.05%. The longest streak of consecutive positive years was 3, and the longest losing streak was 3 years. DRREDDY achieved double-digit gains (10%+) in 16 years. It suffered double-digit losses in 4 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +1.64% | ₹1,271.40 | ₹1,292.30 |
| 2025 | -7.85% | ₹1,379.75 | ₹1,271.40 |
| 2024 | +20.45% | ₹1,145.49 | ₹1,379.75 |
| 2023 | +37.89% | ₹830.71 | ₹1,145.49 |
| 2022 | -13.05% | ₹955.40 | ₹830.71 |
| 2021 | -5.29% | ₹1,008.81 | ₹955.40 |
| 2020 | +82.24% | ₹553.55 | ₹1,008.81 |
| 2019 | +10.70% | ₹500.03 | ₹553.55 |
| 2018 | +9.32% | ₹457.39 | ₹500.03 |
| 2017 | -20.53% | ₹575.53 | ₹457.39 |
| 2016 | -1.00% | ₹581.33 | ₹575.53 |
| 2015 | -3.72% | ₹603.81 | ₹581.33 |
| 2014 | +28.95% | ₹468.25 | ₹603.81 |
| 2013 | +39.43% | ₹335.82 | ₹468.25 |
| 2012 | +16.96% | ₹287.14 | ₹335.82 |
| 2011 | -4.41% | ₹300.39 | ₹287.14 |
| 2010 | +46.17% | ₹205.51 | ₹300.39 |
| 2009 | +146.62% | ₹83.33 | ₹205.51 |
| 2008 | -35.63% | ₹129.47 | ₹83.33 |
| 2007 | -9.22% | ₹142.62 | ₹129.47 |
| 2006 | +66.49% | ₹85.66 | ₹142.62 |
| 2005 | +13.76% | ₹75.30 | ₹85.66 |
| 2004 | -39.05% | ₹123.55 | ₹75.30 |
| 2003 | +59.82% | ₹77.30 | ₹123.55 |
| 2002 | -2.73% | ₹79.47 | ₹77.30 |
| 2001 | +44.94% | ₹54.83 | ₹79.47 |
| 2000 | -8.73% | ₹60.07 | ₹54.83 |
| 1999 | +186.31% | ₹20.98 | ₹60.07 |
| 1998 | +50.77% | ₹13.92 | ₹20.98 |
| 1997 | +105.66% | ₹6.77 | ₹13.92 |
DRREDDY Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Dr. Reddy's Laboratories Limited as an investment
Valuation
DRREDDY currently trades at a trailing P/E ratio of 19.0, which is considered moderate relative to the broader market. The forward P/E of 23.5 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 2.9. The price-to-sales ratio is 3.1.
Dividends
Dr. Reddy's Laboratories Limited pays a dividend to shareholders with a current yield of 0.62%. This translates to $8.00 per share annually. The payout ratio of 12% indicates sustainable dividend coverage.
Risk & Volatility
DRREDDY has a beta of 0.31, indicating it is less volatile than the overall market. The stock's 52-week range is $1020.00 to $1379.70, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 38 analyst opinions, DRREDDY has a consensus "hold" rating. The average price target of $1312.56 suggests 1.6% upside from current levels.
Frequently Asked Questions: DRREDDY
What sector is DRREDDY in? ▼
DRREDDY operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has DRREDDY performed historically? ▼
Over 30 years of trading history, DRREDDY has posted gains in 18 years (60% of the time). The best year was 1999 with a +186.3% return. Past performance does not guarantee future results.
How can I invest in DRREDDY? ▼
You can invest in DRREDDY through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold DRREDDY.
Does DRREDDY pay dividends? ▼
Dr. Reddy's Laboratories Limited pays a dividend to shareholders with a current yield of 0.62%. This translates to $8.00 per share annually. The payout ratio of 12% indicates sustainable dividend coverage.
What does Dr. Reddy's Laboratories Limited do? ▼
Dr. Reddy's Laboratories Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Hyderabad, India.
What sector is DRREDDY in? ▼
DRREDDY operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did DRREDDY go public? ▼
Dr. Reddy's Laboratories Limited went public in 1996, making it a 30-year-old public company as of 2026.
How much would $1,000 invested in DRREDDY 5 years ago be worth today? ▼
A $1,000 investment in DRREDDY five years ago would be worth approximately $1,376 today, representing a 37.6% return.
Does DRREDDY pay dividends? ▼
Yes, Dr. Reddy's Laboratories Limited pays a dividend with a current yield of 0.62%, which is $8.0 per share annually.
What is DRREDDY's market cap? ▼
Dr. Reddy's Laboratories Limited has a market capitalization of $1.1 trillion, classifying it as a mega-cap company.
What is DRREDDY's P/E ratio? ▼
DRREDDY has a trailing P/E ratio of 19.0 and a forward P/E of 23.5, which measures how much investors are paying per dollar of earnings.
Is DRREDDY a buy, hold, or sell? ▼
Based on 38 opinions, DRREDDY has a consensus "hold" rating. The average price target is $1312.56.
Last updated: 3/14/2026